Apotheek Membruggen SRL
Apotheek Membruggen reported total assets of 89,331 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jan 2026).
The score of Apotheek Membruggen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Membruggen's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 26 Jan 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 02 Feb 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
Apotheek Membruggen's financial analysis
- Solvency15.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Membruggen
Apotheek Membruggen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0437.828.108
- VAT number
- BE0437828108
- Peppol
- Registered · 0208:0437828108 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jun 1989
- Registered office
- 3770 Riemst
- Latest accounts
- 2025 · filed on 26 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Membruggen (SRL) has been based in Riemst since 1989, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 91 € and equity of 13,708 €; its revenue is not published. Its solvency stands at 15.3%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Membruggen
Companies in the same business, of comparable size and area, outside its group.
- Manon De Marez Retail sale of pharmaceutical products Herent · balance sheet 85,130 €
- Montpharma Retail sale of pharmaceutical products Forest · balance sheet 135,487 €
- FarmaST Retail sale of pharmaceutical products Zonhoven · balance sheet 107,177 €
- Mega Pharma Retail sale of pharmaceutical products Merchtem · balance sheet 150,288 €
- Pharmacie Gilisquet Retail sale of pharmaceutical products Schaerbeek · balance sheet 391,819 €
- Hacklo Retail sale of pharmaceutical products Hasselt · balance sheet 159,726 €
- Sivahe Retail sale of pharmaceutical products Hasselt · balance sheet 172,297 €
- PTMS Consultancy Retail sale of pharmaceutical products Londerzeel · balance sheet 192,606 €
Frequently asked questions about Apotheek Membruggen
What is the revenue of Apotheek Membruggen?
Apotheek Membruggen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Membruggen?
In Belgium, the VAT number is the company number prefixed with BE: BE0437828108 for Apotheek Membruggen, if the company is VAT-registered. Its company number (CBE) is 0437.828.108.
Where is the registered office of Apotheek Membruggen?
According to the CBE register, the registered office of Apotheek Membruggen is in 3770 Riemst.
What is the equity of Apotheek Membruggen?
At the close of the 2025 financial year, the equity of Apotheek Membruggen amounts to 13,708 €, a solvency of 15.3% of total assets.
Who manages Apotheek Membruggen?
The register lists 2 active mandates at Apotheek Membruggen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Membruggen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →